(Q38341678)

2 September 2017

title

Leptin treatment markedly increased plasma adiponectin but barely decreased plasma resistin of ob/ob mice (English)

1 reference

2 September 2017

Marie-Laure Delporte

1

1 reference

2 September 2017

Samira Ait El Mkadem

series ordinal

2

1 reference

2 September 2017

Muriel Quisquater

series ordinal

3

1 reference

2 September 2017

Sonia M Brichard

series ordinal

4

1 reference

2 September 2017

publication date

4 May 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

2 September 2017

published in

1 reference

2 September 2017

volume

287

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

E446-53

1 reference

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Evidence for a novel peripheral action of leptin as a metabolic signal to the adrenal gland: leptin inhibits cortisol release directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The influence of vanadate on insulin counter-regulatory hormones in obese fa/fa rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Leptin induces angiopoietin-2 expression in adipose tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Transplantation of adipose tissue lacking leptin is unable to reverse the metabolic abnormalities associated with lipoatrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Central leptin regulates the UCP1 and ob genes in brown and white adipose tissue via different beta-adrenoceptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Hyperadiponectinaemia in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

21 January 2018

Adipose tissue hormones

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

AdipoQ is a novel adipose-specific gene dysregulated in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Adipocyte-selective reduction of the leptin receptors induced by antisense RNA leads to increased adiposity, dyslipidemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Disruption of adiponectin causes insulin resistance and neointimal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Decreased food intake does not completely account for adiposity reduction after ob protein infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Lipopolysaccharide increases resistin gene expression in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Resistin expression and regulation in mouse pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Possible role for TNF-alpha in early embryopathy associated with maternal diabetes in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Improvement of glucose homeostasis and hepatic insulin resistance in ob/ob mice given oral molybdate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The role of neuropeptide Y in the antiobesity action of the obese gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Resistin and obesity-associated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00488.2003

10.1152/AJPENDO.00488.2003

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference